About Venneos
Venneos is a company based in Stuttgart (Germany) founded in 2014 by David Wehner, Ralf Zeitler, and Jonas Lehmann. It operates as a B2B. Venneos has raised $1.12 million across 2 funding rounds from investors including Max-Planck-Gesellschaft, Born2Grow and High-Tech Gründerfonds. Venneos operates in a competitive market with competitors including Mekonos, MicroX Labs, Redbud Labs, Neo Nanotech and Pi Mems, among others.
- Headquarter Stuttgart, Germany
- Founders David Wehner, Ralf Zeitler, Jonas Lehmann
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.12 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Max-Planck-Gesellschaft
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Venneos
Venneos has successfully raised a total of $1.12M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Venneos
Venneos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Max-Planck-Gesellschaft, Born2Grow and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Ombudsman services for scientific misconduct in research are provided confidentially.
|
Locked | Locked | Locked |
Investor details for Venneos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Venneos
Investment portfolio details for Venneos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Venneos
Detailed financials for Venneos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Venneos Comparisons
Peer comparison for Venneos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Venneos
Venneos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mekonos, MicroX Labs, Redbud Labs, Neo Nanotech and Pi Mems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Silicon-based nanomachine chips are developed for cell engineering applications.
|
|
| Locked | Locked | Locked |
MEMS-based biochips are developed for blood cell counting.
|
|
| Locked | Locked | Locked |
Microfluidic platforms for biosensing and sample processing are manufactured.
|
|
| Locked | Locked | Locked |
MEMS-based biochips are manufactured for disease diagnosis and sample processing.
|
|
| Locked | Locked | Locked |
Titanium-based MEMS devices are developed for microelectronic thermal solutions.
|
Detailed competitors of Venneos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Venneos
Complete news archive for Venneos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venneos
Venneos was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Venneos is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.
Venneos is a funded company, having raised a total of $1.12M across 2 funding rounds to date.
Venneos, backed by 1117528.0 from Born2Grow, Max-Planck-Gesellschaft, HTGF, focuses on providing healthcare solutions, advancing biotech innovations, medical imaging, and cell analysis systems. Provides a silicon chip-based imaging system for analyzing biological cells. Driving innovation, growth, and excellence in its industry sectors.
Venneos's top competitors include Mekonos, MicroX Labs and Redbud Labs.
Venneos has 3 investors. Key investors include Max-Planck-Gesellschaft, Born2Grow, and High-Tech Gründerfonds.